Nuclear imaging of HDAC expression in GB may improve the understanding and roleplay of HDAC enzymes within gliomagenesis, identify patients likely to benefit from HDACi-targeted therapy and aid in optimizing therapeutic doses of novel HDACi for glioma treatment [163]. This evidence concerns the gene HDAC9 and glioma.